3rd Quarter - Report — THE MICHAEL J. FOX FOUNDATION FOR PARKI… for THE MICHAEL J. FOX FOUNDATION FOR PARKI… (2020)

Firm

THE MICHAEL J. FOX FOUNDATION FOR PARKINSON'S RESEARCH

Client

THE MICHAEL J. FOX FOUNDATION FOR PARKINSON'S RESEARCH

Income

—

Expenses

$18,400

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

7 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Support of pharmaceutical innovation Changes to The Prescription Drug User Fee Act S.475 - RxCAP Act of 2019 Support of an out-of-pocket spending cap for Medicare Part D Support for Value Based Arrangements in Medicare and Medicaid

Lobbyist	Covered position, as disclosed
BRITTANY MEYER	Senior Associate Director, Public Policy
TED THOMPSON	Senior Vice President, Public Policy

Contacted: Food & Drug Administration (FDA); Natl Institutes of Health (NIH); SENATE; Environmental Protection Agency (EPA); HOUSE OF REPRESENTATIVES

Bills named: S. 475 (116th)

Veterans VET

Parkinsons Disease Research, Education and Clinical Centers (PADRECCs) at the Department of Veterans Affairs and the Medical Services Account H.R.663 / S. 191 - Burn Pits Accountability Act H.R. 2500- National Defense Authorization Act for Fiscal year 2020 S. 4049-National Defense Authorization Act for Fiscal Year 2021 H.R.5610- Fair Care for Vietnam Veterans Act

Lobbyist	Covered position, as disclosed
BRITTANY MEYER	Senior Associate Director, Public Policy

Contacted: Food & Drug Administration (FDA); SENATE; Natl Institutes of Health (NIH); Environmental Protection Agency (EPA); HOUSE OF REPRESENTATIVES

Bills named: S. 4049 (116th), S. 191 (116th), H.R. 2500 (116th), H.R. 5610 (116th), H.R. 663 (116th)

Health Issues HCR

H.R. 7663- Protecting Access to Post-COVID-19 Telehealth Act of 2020 H.R.7078, the Evaluating Disparities and Outcomes of Telehealth During the COVID-19 Emergency Act of 2020 Expand eligibility for paid family and medical leave for high-risk individuals during the pandemic Telehealth guidelines for making the flexibilities permanent Medicaid non-emergency medical transportation (NEMT) Improving Seniors Timely Access to Care Act (H.R. 3107) S. 1384, the Prescription Drug Rebate Reform Act of 2019 S.475 - RxCAP Act of 2019 H.R. 945/S. 286, the Mental Health Access Improvement Act of 2019 H.R. 601 - Medical Cannabis Research Act of 2019 Support of an out-of-pocket spending cap for Medicare Part D Support for Value Based Arrangements in Medicare and Medicaid Coronavirus Aid, Relief, and Economic Security Act General information about Parkinson's disease, the need for research funding, and protecting access to care

Lobbyist	Covered position, as disclosed
AARON POLACEK New	Public Policy Officer
TED THOMPSON	Senior Vice President, Public Policy

Contacted: Natl Institutes of Health (NIH); SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Environmental Protection Agency (EPA)

Bills named: H.R. 601 (116th), S. 475 (116th), H.R. 7663 (116th), H.R. 3107 (116th), H.R. 7078 (116th), H.R. 945 (116th), S. 1384 (116th), S. 286 (116th)

Medicare/Medicaid MMM

H.R.3772- Medicare Diagnostic Radiopharmaceutical Payment Equality Act of 2019 H.R. 7078, the Evaluating Disparities and Outcomes of Telehealth During the COVID-19 Emergency Act of 2020 Medicaid non-emergency medical transportation (NEMT) S.475 - RxCAP Act of 2019 H.R. 945/S. 286, the Mental Health Access Improvement Act of 2019 Support of an out-of-pocket spending cap for Medicare Part D Support for Value Based Arrangements in Medicare and Medicaid

Lobbyist	Covered position, as disclosed
TED THOMPSON	Senior Vice President, Public Policy

Contacted: Natl Institutes of Health (NIH); Environmental Protection Agency (EPA); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 945 (116th), S. 475 (116th), S. 286 (116th), H.R. 3772 (116th), H.R. 7078 (116th)

Budget/Appropriations BUD

Parkinsons Disease Research, Education and Clinical Centers (PADRECCs) at the Department of Veterans Affairs and the Medical Services Account Federal appropriations for National Institutes of Health and the Centers for Disease Control; Federal appropriations for Department of Defense Medical Research Programs Federal appropriations for Food and Drug Administration Federal appropriations for Department of Defense Medical Research Programs The Coronavirus Aid, Relief, and Economic Security Act (CARES)

Lobbyist	Covered position, as disclosed
BRITTANY MEYER	Senior Associate Director, Public Policy
TED THOMPSON	Senior Vice President, Public Policy

Contacted: Environmental Protection Agency (EPA); SENATE; Food & Drug Administration (FDA); Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES

Agriculture AGR

Environmental agitators of Parkinson's disease HR 7940 / S 4406 Protect Americas Children from Toxic Pesticides Act HR 230 Ban Toxic Pesticides Act of 2019 HR 3817 Protect Against Paraquat Act

Lobbyist	Covered position, as disclosed
BRITTANY MEYER	Senior Associate Director, Public Policy
TED THOMPSON	Senior Vice President, Public Policy

Contacted: Natl Institutes of Health (NIH); Environmental Protection Agency (EPA); Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 7940 (116th), H.R. 230 (116th), H.R. 3817 (116th)

Environment/Superfund ENV

Environmental Protection Agency's Transparency Rule Cost / Benefit analysis

Lobbyist	Covered position, as disclosed
BRITTANY MEYER	Senior Associate Director, Public Policy

Contacted: SENATE; Environmental Protection Agency (EPA); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.